US health officials urge CDC to validate high-volume measles tests
Health officials from California, Hawaii, Oregon, and Washington are asking the CDC to reconsider its focus on emerging technologies to prioritize rapid measles testing.

Health officials in California, Hawaii, Oregon, and Washington have asked the CDC to reconsider its prioritization of emerging technologies and instead validate a rapid, high-volume measles test. The alliance requested that the CDC develop an assay for measles diagnostic testing on the Panther Fusion and publish the protocol so any laboratory can run the tests.
Currently, laboratories rely on lower-volume tests for measles, such as individual polymerase chain reaction (PCR) tests. High-throughput tests can process many samples at once and can be faster and easier than manual testing. During the Covid pandemic, most public health labs purchased high-volume equipment like the Hologic Panther Fusion, which can process up to 500 tests in eight hours.
The alliance stated that without high-throughput capacity, it would be more difficult to scale up diagnostic testing during a large outbreak, which could impair patient care and public health investigations. Benjamin Bradley, an assistant professor of pathology at the University of Utah and medical director of virology at ARUP, said that in a measles outbreak, time is of the essence. One measles patient can infect 12 to 18 other unvaccinated people, and the virus can linger in the air for two hours.
Quicker tests could help identify and isolate positive patients and lead to faster contact tracing. This would also allow officials to promptly offer vaccines to anyone exposed who is not already vaccinated, as vaccines can prevent infection if taken within 72 hours of exposure.
The CDC is ensuring state and local health departments have support to strengthen measles detection and outbreak response. An agency spokesperson, Emily Hilliard, said the CDC is prioritizing emerging technologies to respond to the measles outbreak.
Texas state laboratories developed a high-volume test during a measles outbreak in west Texas last year, but they have not distributed or published the protocol. ARUP Laboratories published its measles assay in the Journal of Clinical Microbiology in December. The CDC has reportedly completed studies on the assays from Texas and ARUP Laboratories, but these were not full validations or a comprehensive comparison, according to the west coast officials.
Key facts
- Health officials in California, Hawaii, Oregon, and Washington are asking the CDC to validate high-volume measles tests.
- Current measles testing relies on lower-volume tests like individual PCR tests.
- The Hologic Panther Fusion platform can process up to 500 tests in eight hours.
Three perspectives
Neutral
Health officials are requesting that the CDC validate high-volume measles testing protocols to improve outbreak response.
Positive
High-throughput tests could help identify and isolate patients more quickly and facilitate faster contact tracing.
Negative
Without high-throughput capacity, scaling up diagnostic testing during a large outbreak would be more difficult.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.